Cargando…
Structural and functional characterization of a monoclonal antibody blocking TIGIT
TIGIT is an immune checkpoint receptor that is expressed on subsets of activated T cells and natural killer (NK) cells. Several ligands for TIGIT, including poliovirus receptor (PVR), are expressed on cancer cells and mediate inhibitory signaling to suppress antitumor activities of the immune cells....
Autores principales: | Jeong, Bo-Seong, Nam, Hyemi, Lee, Jeewon, Park, Hye-Young, Cho, Ki Joon, Sheen, Joong Hyuk, Song, Eunjung, Oh, Meesook, Lee, Sunggeun, Choi, Hyemin, Yang, Jung-Eun, Kim, Munkyung, Oh, Byung-Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803117/ https://www.ncbi.nlm.nih.gov/pubmed/35090381 http://dx.doi.org/10.1080/19420862.2021.2013750 |
Ejemplares similares
-
Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy
por: Lee, Jeewon, et al.
Publicado: (2020) -
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Lee, Sua, et al.
Publicado: (2021) -
Implication of TIGIT(+) human memory B cells in immune regulation
por: Hasan, Md Mahmudul, et al.
Publicado: (2021) -
TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020) -
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
por: Zhou, Xiuman, et al.
Publicado: (2020)